Assyro AI

Orange Book product · Brand (NDA)

RECLAST

ZOLEDRONIC ACID

Brand (NDA)NDA 021817TE APRX SANDOZ

At a glance

Apr 16, 2007

Approved

Brand (NDA)

Application

AP

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Apr 16, 2007

    19 yr 5 mo ago

  2. Today

  3. Patent 7932241 expires

    Listed drug product patent expiration.

    Feb 05, 2028

    in 1 yr 8 mo

  4. Patent 7932241*PED expires

    Listed listed patent expiration.

    Aug 05, 2028

    in 2 yr 2 mo

Pharmaceutical detail

Active ingredient

ZOLEDRONIC ACID

Strength

EQ 5MG BASE/100ML

Dosage form

INJECTABLE

Route

INTRAVENOUS

TE code

AP

Application

NDA 021817

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7932241Feb 05, 2028in 1 yr 8 mo
Product
7932241*PEDAug 05, 2028in 2 yr 2 mo
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.